Leonite Fund I, Lp - Net Worth and Insider Trading
Leonite Fund I, Lp Net Worth
The estimated net worth of Leonite Fund I, Lp is at least $266,888 dollars as of 2024-09-20. Leonite Fund I, Lp is the of Pasithea Therapeutics Corp and owns about 54,467 shares of Pasithea Therapeutics Corp (KTTA) stock worth over $266,888. Details can be seen in Leonite Fund I, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Leonite Fund I, Lp has not made any transactions after 2022-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Leonite Fund I, Lp
Leonite Fund I, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Leonite Fund I, Lp owns 1 companies in total, including Pasithea Therapeutics Corp (KTTA) .
Click here to see the complete history of Leonite Fund I, Lp’s form 4 insider trades.
Insider Ownership Summary of Leonite Fund I, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp | 2022-08-19 | other: Member of 10% owner group |
Leonite Fund I, Lp Latest Holdings Summary
Leonite Fund I, Lp currently owns a total of 1 stock. Leonite Fund I, Lp owns 54,467 shares of Pasithea Therapeutics Corp (KTTA) as of August 19, 2022, with a value of $266,888.
Latest Holdings of Leonite Fund I, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp | 2022-08-19 | 54,467 | 4.90 | 266,888 |
Holding Weightings of Leonite Fund I, Lp
Leonite Fund I, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Leonite Fund I, Lp has made a total of 1 transactions in Pasithea Therapeutics Corp (KTTA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pasithea Therapeutics Corp is the acquisition of 2,732 shares on August 19, 2022, which cost Leonite Fund I, Lp around $71,037.
Insider Trading History of Leonite Fund I, Lp
- 1
Leonite Fund I, Lp Trading Performance
GuruFocus tracks the stock performance after each of Leonite Fund I, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leonite Fund I, Lp is -21.48%. GuruFocus also compares Leonite Fund I, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leonite Fund I, Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Leonite Fund I, Lp's insider trading performs compared to the benchmark.
Performance of Leonite Fund I, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.61 | | | | | |
| Relative Return to S&P 500(%) | -3.84 | | | | | |
Leonite Fund I, Lp Ownership Network
Leonite Fund I, Lp Owned Company Details
What does Pasithea Therapeutics Corp do?
Who are the key executives at Pasithea Therapeutics Corp?
Leonite Fund I, Lp is the other: Member of 10% owner group of Pasithea Therapeutics Corp. Other key executives at Pasithea Therapeutics Corp include Chief Development Officer Graeme Martin Currie , 10 percent owner Paul B Manning , and 10 percent owner Bradford Manning .
Pasithea Therapeutics Corp (KTTA) Insider Trades Summary
Over the past 18 months, Leonite Fund I, Lp made no insider transaction in Pasithea Therapeutics Corp (KTTA). Other recent insider transactions involving Pasithea Therapeutics Corp (KTTA) include a net purchase of 30,000 shares made by Lawrence Steinman ,
In summary, during the past 3 months, insiders sold 0 shares of Pasithea Therapeutics Corp (KTTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pasithea Therapeutics Corp (KTTA) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.
Pasithea Therapeutics Corp (KTTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pasithea Therapeutics Corp Insider Transactions
Leonite Fund I, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Leonite Fund I, Lp. You might contact Leonite Fund I, Lp via mailing address: 1 Hillcrest Center Drive, Spring Valley Ny 10977.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
